Target
Vascular endothelial growth factor A
Ligand
BDBM282757
Substrate
n/a
Meas. Tech.
Scintillation Proximity Assay (SPA)
pH
7.5±n/a
IC50
3000±n/a nM
Comments
extracted
Citation
 Dixon, DDGrina, JJosey, JARizzi, JPSchlachter, STWallace, EMWang, BWehn, PXu, RYang, H Cyclic sulfone and sulfoximine analogs and uses thereof US Patent  US9884843 Publication Date 2/6/2018 
Target
Name:
Vascular endothelial growth factor A
Synonyms:
VEGF | VEGF-A | VEGFA | VEGFA_HUMAN | VPF | Vascular endothelial growth factor (VEGF) | Vascular endothelial growth factor A (VEGF) | Vascular endothelial growth factor A (VEGF2) | Vascular permeability factor
Type:
Protein
Mol. Mass.:
27063.81
Organism:
Homo sapiens (Human)
Description:
P15692
Residue:
232
Sequence:
MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR
  
Inhibitor
Name:
BDBM282757
Synonyms:
US9884843, Compound 101
Type:
Small organic molecule
Emp. Form.:
C15H8BrF5O4S
Mol. Mass.:
459.183
SMILES:
OC1(CS(=O)(=O)c2ccc(Oc3cc(F)cc(F)c3)c(Br)c12)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: